Pharmaniaga To Join In Saudi Arabia $36.6 Million Drug Plant JV
This article was originally published in PharmAsia News
Executive Summary
Malaysia's Pharmaniaga has agreed to join a major Saudi Arabia investment company in a 50-50 joint venture to build a $36.6 million drug-production plant in Riyadh and broaden the drug maker's presence.